Alexion Receives Orphan Drug Status For Dermatomyositis Treatment

The FDA has granted Orphan Drug status to Alexion Pharmaceuticals, Inc.’s humanized monoclonal antibody C5 Complement Inhibitor 5G1.1 for the treatment of patients with dermatomyositis. Alexion is currently enrolling patients in a Phase Ib pilot clinical trial that is designed to gather clinical data regarding the safety profile and biological and clinical effects of 5G1.1 Read more about Alexion Receives Orphan Drug Status For Dermatomyositis Treatment[…]

Curagen And Gemini Enter Genome Wide Drug Target Discovery And Pharmacogenetics Collaboration

CuraGen Corporation, an integrated genomics based drug discovery and development company, and Gemini Genomics plc, announced today the largest collaboration to date linking cSNPs (human genetic variations) and clinical information to identify and validate novel drug targets for use in the discovery and development of pharmaceutical and diagnostic products. Specifically, CuraGen and Gemini scientists will Read more about Curagen And Gemini Enter Genome Wide Drug Target Discovery And Pharmacogenetics Collaboration[…]

Millennium And Morphosys Extend Collaboration

Millennium Pharmaceuticals, Inc. has signed an agreement for an expanded alliance with MorphoSys AG. Under their agreement, MorphoSys AG will apply its proprietary HuCAL technology to generate human antibodies for a new target molecule in inflammatory disorders provided by Millennium. One of the objectives of the alliance is to develop fully human antibodies against targets Read more about Millennium And Morphosys Extend Collaboration[…]

Pharmagenesis, Inc.

Fujisawa Enters Research Agreement With Pharmagenesis

Fujisawa Pharmaceutical Co., Ltd., has executed a collaborative research agreement with Pharmagenesis, Inc., with regard to triptolide derivatives, novel and potent immunosuppressants created by Pharmagenesis. The agreement also gives Fujisawa an option to acquire the exclusive and worldwide (certain territories are under negotiation) development and marketing rights to Pharmagenesis’ compounds in the therapeutic areas of Read more about Fujisawa Enters Research Agreement With Pharmagenesis[…]

Buy Dragon Pharma LLC Safely

Sustanon 350 - Cheap Price

Administration: Injection
Active Ingredient: Testosterone Blend
Manufacturer: Dragon Pharma Labs
Unit: 20 x 10 mL vial (350 mg/mL)
Price: 20 x $40.00

Trenbolone 100

Injectable Anabolic Steroid
Basal Substance: Trenbolone Acetate
Manufacturer: Dragon Pharma
Amount: 1 X 10 ml (100 mg/ml)

Masteron 100 - Bulk Price

Administration: Injection
Active Component: Drostanolone Di-Propionate
Branded by: Dragon Pharma
Amount: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $49.00

Cut Long 300

Injectable Anabolic Steroid
Basic Constituent: Drostanolone Enanthate, Testosterone Enanthate, Trenbolone Enanthate
Producer: Dragon Pharmaceutical
Unit: 1 X 10 ml (300 mg/ml)

Masteron 100

Injectable Anabolic Steroid
Basal Ingredient: Drostanolone Di-Propionate
Manufacturer: Dragon Pharmaceuticals
Unit: 1 X 10 ml (100 mg/ml)

NPP 150

Injectable Anabolic Steroid
Principal Ingredient: Nandrolone Phenylpropionate
Manufacturer: Dragon Pharma Labs
Unit: 1 X 10 ml (150 mg/ml)

Deca 500

Injectable Steroid for Muscle Growth
Prime Substance: Nandrolone Decanoate
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (500 mg/mL)

Primobolan 100

Injectable Steroid for Muscle Growth
Primary Component: Methenolone Enanthate
Produced by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (100 mg/mL)

Trenbolone 200 [10 Vials]

Injectable Steroid for Muscle Growth
Primary Substance: Trenbolone Enanthate
Manufacturer: Dragon Pharma
10 Vials [10 mL per Vial (200 mg/ml)]
Price: 10 x $77.00 = $770.00 in Total

NPP 150 [10 Vials]

Injectable Steroid for Muscle Growth
Main Substance: Nandrolone Phenylpropionate
Branded by: Dragon Pharmaceutical
10 Vials [10 mL per Vial (150 mg/ml)]
Price: 10 x $30.00 = $300.00 in Total

Enantat 400

Main Substance: Testosterone Enanthate
Manufacturer: Dragon Pharmaceuticals
Unit: 10 mL vial (400 mg/mL)

Clenbuterol

Prime Component: Clenbuterol Hydrochloride
Producer: Dragon Pharmaceuticals
Amount: 100 tablets (40 mcg/tablet)